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Is Hepatic Artery Thrombosis After Liver Transplantation Really a Surgical 
Complication? 
K. Yanaga, L. Makowka, and T.E. Starzl 
T HE COM PLICA nON of hepatic arterial thrombosis (HAT) leads to an [!lmost universally fatal outcome 
without retransplantation. 1•4 Although this problem occurs in 
both adults and children, its incidence is significantly higher 
in the pediatric population, where it remains one of the major 
causes of mortality and retransplantationY Some of the 
known causes of HAT after orthotopic liver transplantation 
(OLT) are purely technical. These include clamp traction on 
the recipient hepatic artery (HA), faulty placement of 
anastomotic sutures, and the inappropriate angulation of the 
donor HA or anastomotic site. 2•5 
Certain non-technical factors have been reported to pre-
dispose to HAT after OL T.1.1,6 In this analysis, these factors 
were investigated in 13 patients who sustained HAT either 
during or after OL T and who underwent an attempt at 
secondary arterial reconstruction. 
MATERIALS AND METHODS 
During the I-year period between January I and December 31, 
1987, 323 patients underwent 389 OL T at the University of Pitts-
burgh Health Center. HAT developed in 37 of these grafts (9.5%) 
during or shortly after OLT. The incidence was 5.7% in adults 
(16/282 patients) and 19.6% in children (21/107 patients). An 
attempt at HAT reconstruction was made in 13 of these 37 patients 
(35.1 %). This was performed during the primary transplantation 
procedure in 6 patients and 4.7 ± 3.5 days later (mean ± SD; range 
1 to 12) in the other 7 patients. The patients were aged between 17 
months and 58 years, with a mean age of 22.0 years; 7 were female 
(53.8%). Objective evaluation of the etiology and factors responsible 
for the development of HAT in these 13 patients was undertaken at 
the time of reconstruction. The evaluation included HA blood flow 
measurements using an electromagnetic flowmeter lO and revision of 
the HA anastomosis with close inspection of the anastomotic site. 
Immediately following surgery, all pediatric patients were given 
intravenous low molecular weight dextran 5-10 mL/kg for 4 days, 
heparin 50 U /kg subcutaneously every 12 hours throughout the 
hospital stay (approximately 4 weeks), aspirin 20-40 mg/day by 
mouth or nasogastric tube for at least 3 months, and dipyridamole 
(Persantine) 12.5-25 mg/day by mouth for at least 3 months. The 
above anticoagulation or antiplatelet therapy was discontinued if the 
patient demonstrated any clinical or laboratory evidence of coagulo-
pa!hy. All adult patients who underwent OLT for Budd-Chiari 
syndrome received anticoagulation with heparin 5,000 units subcu-
taneously, three times a day, followed by coumadin in a dose that 
maintained the prothrombin time at around 18 seconds. 
RESULTS 
Table 1 lists the clinical data of the patients who developed 
HAT during the actual transplant procedure. Possible causes 
of HAT in these patients included one case of poor inflow 
related to an arterial anomaly in the recipient, one case of 
rotation of an aortohepatic interposition graft in the retro-
pancreatic tunnel, one case of intimal dissection of the 
recipient common HA due to excessive traction, and one case 
of disseminated intravascular coagulation (DIC) of the 
donor. There were no obvious significant factors in two other 
cases. 
Table 2 lists the clinical data of the patients who developed 
HA T following OL T. Possible etiologic factors included one 
case of poor inflow related to an arterial anomaly of the 
recipient, one case of a marked discrepancy in size between 
the donor celiac axis and a donor iliac artery which had been 
used as an aortohepatic interposition graft, one case involv-
ing an end-to-side anastomosis, one case involving kinking of 
the anastomosis; and one instance of an infected donor 
hepatic artery. Two other patients did not reveal any obvious 
causes. 
The etiology of HAT among the 13 patients was thus 
ascribed to purely technical factors in 5 (38.5%), poor inflow 
related to an arterial anomaly of the recipient in 2 (15.4%), 
DIC of the donor in I (7.7%), infection of the donor HA in I 
(7.7%) and unknown causes in 4 patients (30.8%). 
DISCUSSION 
Other authors have reported multiple causes of HAT, includ-
ing poor technical performance, uncontrolled rejection, high 
postoperative hematocrit, and in cases of pediatric OL T, 
small caliber of the vessels with associated low flow (Table 
3).1-3.6.7.10 
Untreated rejection is associated with marked reduction of 
hepatic blood flow in dogs following OL T, presumably due to 
increased resistance in the hepatic vascular tree.s This would 
imply that uncontrolled rejection may be one of the patho-
genic factors of HAT in humans.2•9 
Tisone et al6 recently reported a correlation between HAT 
after OL T and a high hematocrit. A significantly higher 
incidence of HAT (24%) was observed in patients whose 
immediate postoperative hematocrit exceeded 44%, com-
pared with an incidence of 3% in patients with a lower 
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Table 1. Clinical Data of Patients Who Developed Hepatic Artery Thrombosis and Underwent Reconstruction During OL T 
Liver HAAnomaly Initial HA Possible 
Case Age/Sex Disease (D/R) Anastomosis (D I R) Cause of HAT 
291M CAH -/R, P&LHA CA/CHA Poor inflow 
2 
3 
4 
5 
6 
19/F Wilson R&PHA/R&PHA CA/AHIG Rotation of AHIG 
23 mo/F CSA R&PHA/- CA/CHA Unknown 
211M Cystic fibrosis -1- CA/AHIG DIC in the donor 
17 mo/M CSA -1- CA/CHA Unknown 
56/M CAH -1- CA/CHA Intimal dissection 
HA ~ hepatic artery; D/R ~ donor/recipient; CAH ~ chronic active hepatitis; CSA ~ congenital biliary atresia; RHA ~ right hepatic 
artery; PHA ~ proper hepatic artery; LAH ~ left hepatic artery; CHA ~ common hepatic artery; AHIG ~ aortohepatic interposition graft; 
DIC ~ disseminated intravascular coagulation. 
Table 2. Clinical Data of Patients Who Developed Hepatic Artery Thrombosis and Underwent Reconstruction Following OL T 
Liver HA InitialHA Possible 
Case Age/Sex Disease Anomaly Anastomosis POD# Cause 
1 34/F PSC -/R&PHA CA/RHA 12 Poor inflow 
2 30 mo/F CSA -1- CA/CHA 4 Unknown 
3 17 mo/M CSA -1- CA/CHA 1 Unknown 
4 58/F PSC -1- CA/AHIG 3 Stricture due to size discrepancy 
5 181M FLF -1- CA/AHIG 4 End·to·side HA anastomosis 
6 4/F FLF -1- CA/CHA 5 Infection 
7 38/F PSC R&PHA/- Distal SMA/CHA 4 Kinking of anastomosis 
(fold over) 
HA ~ hepatic artery; 01 R ~ donor J recipient; PSC ~ prilTlary biliary cirrhosis; RHA ~ right hepatic artery; PHA ~ proper hepatic artery; 
CA ~ celiac axis; CSA ~ congenital biliary atresia; CHA ~ common hepatic artery; AHIG ~ aortohepatic interposition graft; FLF ~ 
fulminant liver failure; PSC ~ primary sclerosing cholangitis; SMA ~ superior mesenteric artery. 
hematocrit. Overtransfusion, dehydration, or the combina-
tion of both may contribute to the higher incidence of HAT 
among these patients. 
The etiology of HAT in small children remains to be 
elucidated. Measurements of hepatic blood flow revealed an 
extremely high incidence of HAT in grafts with HA flows 
less than 60 mL/min (5 out of 6 patients, 83.3%).10 Further 
analysis of graft hemodynamics as an etiologic factor is in 
progress. 
In adults, if the HA blood flow is 200 mL/min or less, we 
pursue measures to increase the arterial inflow. These 
Table 3. Possible Causes of HepatiC Artery 
Thrombosis Following OL T 
Possible Cause Surgical Factor Medical Factor 
Inflow problem rHA intimal dissection rHA anomalies, ?rHA 
Anastomosis Inversion, stricture 
Kinking 
Donor HA Intimal dissection 
Kinking, HA anomalies 
hypoplasia (chil-
dren) 
Parenchymal sip HAR for HAT, reo 
run-off jection, preserva-
tion, ?ischemia, 
donor DIC 
rHA ~ recipient hepatic artery; HAR ~ hepatic artery recon-
struction; HAT ~ hepatic artery thrombosis; DIC ~ disseminated 
intravascular coagulation. 
include the placement of an aortohepatic interposition arte-
rial graft or ligation of the splenic artery. 
A recent study evaluating the effects of different preserva-
tion fluids on liver allografts demonstrated a significantly 
reduced incidence of HAT in livers preserved in University of 
Wisconsin (UW) solution, as compared with those stored in 
Euro-Collins solution (4.6% vs 12.5%, p < 0.05)11 This may 
indicate that intimal damage or an increase in HA resistance 
from cellular swelling during storagel2 is a contributory 
factor to the development of HAT. 
The cases presented in this report offered a unique oppor-
tunity to examine the possible causes of intraoperative or 
postoperative HAT at the time of attempted reconstruction. 
Nontechnical factors, although less frequent than technical 
failures, accounted for or played a contributory role in the 
development of HAT in 4 of J3 patients (30.8%). 
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